A shadow economy for unlicensed weight-loss drugs is being driven by TikTok fitness influencers and sellers on messaging platforms, based on recent findings.
Experimental Drug Gaining Traction Via Social Media
The experimental drug, which remains in clinical trials, is being advertised by social media influencers for its alleged weight-reducing properties. Followers are urged to message these profiles directly for supplier links, while also receiving discount codes.
Thriving Trade on Social Networks
Separately, a robust market exists on Telegram, where communities with thousands of participants share “before and after” photos, administration instructions and claims of rapid UK delivery. Vendors market the substance there before directing buyers to other platforms for transactions.
Learning About The Experimental Drug
Retatrutide is an experimental injectable created by US drugmaker Eli Lilly. The drug affects three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies indicate it could assist individuals lose up to a quarter of their total weight. Referred to as the “triple G”, the drug is being hailed online as the successor to Ozempic.
Medical Professionals Voice Worries
Nevertheless, doctors and chemists have cautions that the sale of what remains an unapproved drug in the UK is worrisome and could result in users administering products of unknown origin.
Some professionals said the demand for the experimental drug could be connected to the rising price of approved weight loss products such as Mounjaro.
Legal Position and Implementation
Selling the unapproved drug on TikTok or messaging apps is prohibited in the United Kingdom, as it is an unapproved medication that cannot be promoted or distributed for human use under the Human Medicines Regulations 2012.
Several influencers attempt to circumvent the rules by calling to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled substance, but promotion and supply can still violate medicines, advertising, and consumer regulations, potentially leading to penalties, legal action or imprisonment.
Platform Response and Content Removal
According to the social media company, the platform has removed problematic content and prohibited associated keywords and query recommendations. The organization stated it was dedicated to maintaining the service secure and allocating resources in enhancing compliance measures.
Digital Marketplace Activities
Investigations also found communities with up to 9,000 participants selling the experimental drug using Telegram's integrated discovery tool, which operates like a online catalog. Entering “retatrutide” immediately displays groups with thousands of members, filled with images of weight loss, glowing testimonials and detailed guides for preparing or administering at home.
Within minutes of joining one community, a seller posted WhatsApp details, where most transactions take place. The vendor provided an guidebook and guaranteed shipping within two days. When questioned whether the product was authentic, one vendor said: “You can’t be sure.” Another provided a photo of a alleged testing documentation. Not one inquired about weight, health issues or previous experience.
Item Information and Costs
Within these communities, messages show dark colored packages with Royal Mail labels, stating to include fresh supplies. One communication read: “It took eight of us to load them this morning.”
Customers can select between powder vials, prepared at home with sterile water, or pre-filled pens usually priced at 160 pounds for 20mg. When questioned how long a injector should last, sellers give contradictory responses varying between a several days to “depends on your body”.
Service Moderation and Safety Actions
A spokesperson for Telegram stated it actively moderated harmful material on its platform including material that promoted the “misuse of controlled medications”. The organization added that it eliminated “millions of pieces of harmful content each day”.
Medical Professional Warnings
“People are administering materials they can’t verify. Although the research behind this drug is valid, these digital products may not include what they claim,” said Jason Murphy, the director of pharmacy at a pharmacy service.
A medical professional of an online medical service connected the surge in interest to current cost increases for authorized slimming medications such as Mounjaro. “With costs increasing, individuals are turning to online platforms. But fake injections are extremely dangerous. You cannot know what’s contained or whether the environment they were made in was clean,” she said.
Her team has previously encountered individuals injured by personal administration from unconfirmed sources. “We recognize the disappointment, but purchasing from Telegram or communication platforms is gambling with your well-being,” stated the doctor. “These substances could be contaminated or improperly measured.”
Manufacturer Statement
A representative from Eli Lilly said retatrutide was in third stage clinical trials and had not been evaluated or authorized by any regulatory agency globally. “Therefore at this time no one can sell [it] for personal consumption,” they explained, noting that any product “falsely representing itself as a company experimental substance not yet authorized … may subject users to potentially significant health risks”.
